Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Zihan Hou, Aijinxiu Ma, Jiale Mao, Danni Song & Xu Zhao. (2023) Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-15.
Read now
Read now
Arshad Mehmood, Lei Zhao, Chengtao Wang, Muhammad Nadeem, Ali Raza, Nawazish Ali & Amjad Abbas Shah. (2019) Management of hyperuricemia through dietary polyphenols as a natural medicament: A comprehensive review. Critical Reviews in Food Science and Nutrition 59:9, pages 1433-1455.
Read now
Read now
AA Kiadaliri, T Uhlig & M Englund. (2018) Burden of gout in the Nordic region, 1990–2015: findings from the Global Burden of Disease Study 2015. Scandinavian Journal of Rheumatology 47:5, pages 410-417.
Read now
Read now
Yi-Yun Lee, Chao-Hsiun Tang, Jin-Hua Chen, Li-Na Kuo & Yu Ko. (2018) Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study. Current Medical Research and Opinion 34:4, pages 735-740.
Read now
Read now
K-H Yu, J-H Lai, P-N Hsu, D-Y Chen, C-J Chen & H-Y Lin. (2016) Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study. Scandinavian Journal of Rheumatology 45:4, pages 304-311.
Read now
Read now
Paul P. Doghramji, Steve Fermer, Robert Wood, Robert Morlock & Scott Baumgartner. (2016) Management of gout in the real world: current practice versus guideline recommendations. Postgraduate Medicine 128:1, pages 106-114.
Read now
Read now
Puja Khanna, Dinesh Khanna, Chris Storgard, Scott Baumgartner & Robert Morlock. (2016) A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift. Postgraduate Medicine 128:1, pages 34-40.
Read now
Read now
Joseph A. Lieberman$suffix/text()$suffix/text(). (2011) Treatment and Prophylaxis of Gout Flare in the Clinic: An Office-Based Approach to Gout Management. Postgraduate Medicine 123:6, pages 151-165.
Read now
Read now
Articles from other publishers (68)
Jiyong Liu, Dier Shi, Shuna Liu, Kaxi Yu & Xiurong Hu. (2023) Preformulation Study for Seven Solid Forms of Dotinurad. Crystal Growth & Design 23:8, pages 6046-6058.
Crossref
Crossref
Alan Kivitz, Wesley DeHaan, Rehan Azeem, Justin Park, Sheri Rhodes, Jamie Inshaw, Sheldon S. Leung, Savvas Nicolaou, Lloyd Johnston, Takashi K. Kishimoto, Peter G. Traber, Earl Sands & Hyon Choi. (2023) Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110). Rheumatology and Therapy 10:4, pages 825-847.
Crossref
Crossref
Uchenna Estella Odoh, Chukwuebuka Egbuna, Chukwuma Micheal Onyegbulam, Santwana Palai, Ozan Emre Eyupoglu, Charles Oluwaseun Adetunji, Olugbemi Tope Olaniyan, Peculiar Feenna Onyekere, Iqra Yasmin, Rebia Ejaz, Wahab Ali Kha, Daniel Okwudili Nnamani, Christopher Obodike Ezugwu, Madu Ezejiofor, Vincent Obisike Chukwube, Edith Obioma Diovu, Ogechukwu Helen Udodeme & Felix Ifeanyi Nwafor. 2023. Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery. Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery
343
358
.
Gill Verstappen, Olaf Michel, Stijn Halewyck, Vedat Topsakal & Antje Pössneck. (2022) Infected nasal gout tophus: A case report. Clinical Case Reports 10:12.
Crossref
Crossref
John K. Botson, John R. P. Tesser, Ralph Bennett, Howard M. Kenney, Paul M. Peloso, Katie Obermeyer, Yang Song, Brian LaMoreaux, Lin Zhao, Yan Xin, Jason Chamberlain, Srini Ramanathan, Michael E. Weinblatt & Jeff Peterson. (2022) A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Yoon-Young Sung & Dong-Seon Kim. (2022) Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia. BioMed Research International 2022, pages 1-9.
Crossref
Crossref
XinYing Zhu, Chao Yang, Lei Zhang & Jing Li. (2022) Identification of novel dual inhibitors targeting XOR and URAT1 via multiple virtual screening methods. Journal of Molecular Structure 1256, pages 132567.
Crossref
Crossref
John K. Botson & Jeff Peterson. (2022) Pretreatment and Coadministration With Methotrexate Improved Durability of Pegloticase Response. JCR: Journal of Clinical Rheumatology 28:1, pages e129-e134.
Crossref
Crossref
Rehab S. Ramdhan, Noora A. Hade & Rebah N. Algafari. (2021) Association of multiple SNPs at slc2a9 exon 8 in gout disease in Iraqi population: A molecular study. Meta Gene 30, pages 100942.
Crossref
Crossref
Tao Han Lee, Jia-Jin Chen, Chao-Yi Wu, Chih-Wei Yang & Huang-Yu Yang. (2021) Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy. Diagnostics 11:9, pages 1674.
Crossref
Crossref
John K. Botson, John R.P. Tesser, Ralph Bennett, Howard M. Kenney, Paul M. Peloso, Katie Obermeyer, Brian LaMoreaux, Michael E. Weinblatt & Jeff Peterson. (2021) Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR). The Journal of Rheumatology 48:5, pages 767-774.
Crossref
Crossref
Yuesheng Xie, Ling Li, Riqiang Luo, Ting Xu, Lin Yang, Fangping Xu, Haobo Lin, Guangfeng Zhang & Xiao Zhang. (2021) Diagnostic efficacy of joint ultrasonography, dual-energy computed tomography and minimally invasive arthroscopy on knee gouty arthritis, a comparative study. The British Journal of Radiology 94:1121, pages 20200493.
Crossref
Crossref
Yu Hwa Park, Do Hoon Kim, Jung Suk Lee, Hyun Il Jeong, Kye Wan Lee & Tong Ho Kang. (2020) A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial for Evaluation of the Efficacy and Safety of DKB114 on Reduction of Uric Acid in Serum. Nutrients 12:12, pages 3794.
Crossref
Crossref
Tak Kyu Oh & In-Ae Song. (2020) Long-term opioid use among patients with chronic gout: a cross-sectional study of a sample cohort in South Korea. Clinical Rheumatology 39:10, pages 3033-3039.
Crossref
Crossref
Sharon Hannah Barazani, Wei-Wei Chi, Renata Pyzik, Helena Chang, Adam Jacobi, Tom O’Donnell, Zahi A Fayad, Yousaf Ali & Venkatesh Mani. (2020) Quantification of uric acid in vasculature of patients with gout using dual-energy computed tomography. World Journal of Radiology 12:8, pages 184-194.
Crossref
Crossref
Sarah Stewart, Andrea Garcia Guillen, William J. Taylor, Angelo Gaffo, Julia Slark, Merryn Gott & Nicola Dalbeth. (2020) The experience of a gout flare: a meta-synthesis of qualitative studies. Seminars in Arthritis and Rheumatism 50:4, pages 805-811.
Crossref
Crossref
Lin-Lin Jiang, Xue Gong, Ming-Yue Ji, Cong-Cong Wang, Jian-Hua Wang & Min-Hui Li. (2020) Bioactive Compounds from Plant-Based Functional Foods: A Promising Choice for the Prevention and Management of Hyperuricemia. Foods 9:8, pages 973.
Crossref
Crossref
Naomi Schlesinger & Peter E. Lipsky. (2020) Pegloticase treatment of chronic refractory gout: Update on efficacy and safety. Seminars in Arthritis and Rheumatism 50:3, pages S31-S38.
Crossref
Crossref
Bin Zhang, Mingfeng Yang & Hongzhi Wang. (2020) Diagnostic value of ultrasound versus dual-energy computed tomography in patients with different stages of acute gouty arthritis. Clinical Rheumatology 39:5, pages 1649-1653.
Crossref
Crossref
Michael T. Murray & John Nowicki. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
1349
1354.e1
.
Oshima, Shiiya & Nakamura. (2019) Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study. Nutrients 11:11, pages 2562.
Crossref
Crossref
Berenice Rivera-Paredez, Luis Macías-Kauffer, Juan Carlos Fernandez-Lopez, Marisela Villalobos-Comparán, Mayeli M. Martinez-Aguilar, Aldo de la Cruz-Montoya, Eric G. Ramírez-Salazar, Hugo Villamil-Ramírez, Manuel Quiterio, Paula Ramírez-Palacios, Sandra Romero-Hidalgo, María Teresa Villarreal-Molina, Edgar Denova-Gutiérrez, Yvonne N. Flores, Samuel Canizales-Quinteros, Jorge Salmerón & Rafael Velázquez-Cruz. (2019) Influence of Genetic and Non-Genetic Risk Factors for Serum Uric Acid Levels and Hyperuricemia in Mexicans. Nutrients 11:6, pages 1336.
Crossref
Crossref
Giuseppe Luna, Anton V. Dolzhenko & Ricardo L. Mancera. (2019) Inhibitors of Xanthine Oxidase: Scaffold Diversity and Structure‐Based Drug Design. ChemMedChem 14:7, pages 714-743.
Crossref
Crossref
Shunji Oshima, Sachie Shiiya & Yasunori Nakamura. (2019) Serum Uric Acid-Lowering Effects of Combined Glycine and Tryptophan Treatments in Subjects with Mild Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Nutrients 11:3, pages 564.
Crossref
Crossref
Allan H. Morton, Tony Hosey & Brian LaMoreaux. (2018) Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases. Rheumatology and Therapy 5:2, pages 583-594.
Crossref
Crossref
Jasvinder A. Singh. (2018) Goals of gout treatment: a patient perspective. Clinical Rheumatology 37:9, pages 2557-2566.
Crossref
Crossref
Fan Hong, Pengfei Xu & Yonggong Zhai. (2018) The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 19:8, pages 2189.
Crossref
Crossref
Caroline L. Benn, Pinky Dua, Rachel Gurrell, Peter Loudon, Andrew Pike, R. Ian Storer & Ciara Vangjeli. (2018) Physiology of Hyperuricemia and Urate-Lowering Treatments. Frontiers in Medicine 5.
Crossref
Crossref
Tae-Hun LeeIl-Hyun Nam, Gil-Yeong AhnYeong-Hyeon LeeYong-Sik LeeYoung-Deuk ChoiHee-Hyung Lee. (2018) Surgical Treatment of Chronic Tophaceous Gout in the 1st Metatarso-Phalangeal Joint. Journal of Korean Foot and Ankle Society 22:4, pages 156.
Crossref
Crossref
O. V. Zhelyabina & M. S. Eliseev. (2017) DIET IN GOUT AND HYPERURICEMIA. Rheumatology Science and Practice 55:4, pages 436-445.
Crossref
Crossref
Jianjun Xu, Cai Lin, Peng Zhang & Jianghui Ying. (2017) Risk factors for ulceration over tophi in patients with gout. International Wound Journal 14:4, pages 704-707.
Crossref
Crossref
Zancong Shen, Kathy Tieu, David Wilson, Gail Bucci, Michael Gillen, Caroline Lee & Bradley Kerr. (2017) Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment. Clinical Pharmacology in Drug Development 6:4, pages 377-387.
Crossref
Crossref
Sophi Tatlock, Katja Rüdell, Charlotte Panter, Rob Arbuckle, Leslie R. Harrold, William J. Taylor & Tara Symonds. (2016) What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions. The Patient - Patient-Centered Outcomes Research 10:1, pages 65-79.
Crossref
Crossref
Chien-Fang Huang, Ju-Chi Liu, Hui-Chuan Huang, Shao-Yuan Chuang, Chang-I Chen & Kuan-Chia Lin. (2016) Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study. Rheumatology International 37:2, pages 313-322.
Crossref
Crossref
Jeffrey Poiley, Alexandra S. Steinberg, Yun‐Jung Choi, Charles S. Davis, Robert L. Martin, Charles A. McWherter, Pol F. Boudes, H. Bays, D. Bolshoun, E. Bolster, D. Cheung, C. Cone, R. DeGarmo, J. Earl, I. El Asmar, D. Felber, D. Fitz‐Patrick, A. Gaffo, G. Gottschlich, J. Greenwald, C. Griffin, M. Guice, W. Harper, J. Hill, C. Huffman, R. HulingJr.Jr., F. Johnson, S. Kafka, J. Keane, W. Kirby, J. Kirstein, E. Kolettis, G. Lefebvre, A. Mabaquiao, K. Maynard, H. McIlwain, R. McNeill, D. Mehta, R. Montgomery, C. Morgan, J. Poiley, S. Powell, K. Radbill, M. Reschak, R. Surowitz, J. Tarro, M. Turner, F. Velazquez, L. Watkins, J. White, H. Williams, J. Wilson, F. Zaidi, S. Henein, A. Toma, T. Burtchuladze, E. Kartvelishvili, L. Kilasonia, L. Lagvilava, L. Shalamberidze & N. Tsiskarishvili. (2016) A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout. Arthritis & Rheumatology 68:8, pages 2027-2034.
Crossref
Crossref
Daniel PorattKeith Rome. (2016) Surgical Management of Gout in the Foot and Ankle. Journal of the American Podiatric Medical Association 106:3, pages 182-188.
Crossref
Crossref
Shaochen Guan, Zhe Tang, Xianghua Fang, Xiaoguang Wu, Hongjun Liu, Chunxiu Wang & Chengbei Hou. (2016) Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Archives of Gerontology and Geriatrics 64, pages 162-166.
Crossref
Crossref
Keith Rome, Kathryn Erikson, Cynthia Otene, Hazra Sahid, Karyn Sangster & Peter Gow. (2016) Clinical characteristics of foot ulceration in people with chronic gout. International Wound Journal 13:2, pages 209-215.
Crossref
Crossref
Sarah Stewart, Nicola Dalbeth, Alain C. Vandal & Keith Rome. (2015) Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study. Journal of Foot and Ankle Research 8:1.
Crossref
Crossref
Michael A. Becker, David Fitz-Patrick, Hyon K. Choi, Nicola Dalbeth, Chris Storgard, Matt Cravets & Scott Baumgartner. (2015) An open-label, 6-month study of allopurinol safety in gout: The LASSO study. Seminars in Arthritis and Rheumatism 45:2, pages 174-183.
Crossref
Crossref
Gemma E. Shields & Stephen M. Beard. (2015) A Systematic Review of the Economic and Humanistic Burden of Gout. PharmacoEconomics 33:10, pages 1029-1047.
Crossref
Crossref
Christopher E. Ekpenyong & Nyebuk Daniel. (2015) Roles of diets and dietary factors in the pathogenesis, management and prevention of abnormal serum uric acid levels. PharmaNutrition 3:2, pages 29-45.
Crossref
Crossref
Keith Rome & Mike Frecklington. 2015. Management of Chronic Conditions in the Foot and Lower Leg. Management of Chronic Conditions in the Foot and Lower Leg
52
69
.
Peter M. ten Klooster, Harald E. Vonkeman, Martijn A. H. Oude Voshaar, Christina Bode & Mart A. F. J. van de Laar. (2013) Experiences of gout-related disability from the patients’ perspective: a mixed methods study. Clinical Rheumatology 33:8, pages 1145-1154.
Crossref
Crossref
Simon Horsburgh, Pauline Norris, Gordon Becket, Bruce Arroll, Peter Crampton, Jacqueline Cumming, Shirley Keown & Peter Herbison. (2014) Allopurinol use in a New Zealand population: prevalence and adherence. Rheumatology International 34:7, pages 963-970.
Crossref
Crossref
Laura BE Kienhorst. (2014) Gout: A clinical overview and its association with cardiovascular diseases. World Journal of Rheumatology 4:3, pages 62.
Crossref
Crossref
L. Cavagna & W. J. Taylor. (2014) The Emerging Role of Biotechnological Drugs in the Treatment of Gout. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Xavier Tena. (2014) El factor humano en la gota. Seminarios de la Fundación Española de Reumatología 15:1, pages 3-5.
Crossref
Crossref
Qian-Hua Li, Lie Dai, Zhao-Xia Li, Hai-Jun Liu, Chan-Juan Zou, Xia Ou-Yang, Meng Lu, Ting Li, Yan-Hua Li, Yin-Qian Mo & H. Ralph Schumacher. (2013) Questionnaire survey evaluating disease-related knowledge for 149 primary gout patients and 184 doctors in South China. Clinical Rheumatology 32:11, pages 1633-1640.
Crossref
Crossref
Michael A Becker, Herbert S B Baraf, Robert A Yood, Aileen Dillon, Janitzia Vázquez-Mellado, Faith D Ottery, Dinesh Khanna & John S Sundy. (2013) Long-term safety of pegloticase in chronic gout refractory to conventional treatment. Annals of the Rheumatic Diseases 72:9, pages 1469-1474.
Crossref
Crossref
Nicola Dalbeth, Fernando Perez-Ruiz & Naomi SchlesingerFernando Perez-RuizAne AltunaJoana Atxotegi. 2013. Gout. Gout
190
200
.
Yu-Ting Lin, Hui-Wen Lin, Yu-Chen Huang, Wen-Tsao Ho, Yu-Chuan Li & Ting-Jui Chen. (2013) Association between gout and vertigo in a Taiwanese population. Journal of Clinical Neuroscience 20:6, pages 857-861.
Crossref
Crossref
Francesco Bolzetta, Nicola Veronese, Enzo Manzato & Giuseppe Sergi. (2013) Chronic gout in the elderly. Aging Clinical and Experimental Research 25:2, pages 129-137.
Crossref
Crossref
C. L. Teh, Y. K. Cheong, H. N. Ling, P. L. Chan, T. Chan & G. R. Ling. (2011) A profile of gout patients in Sarawak. Rheumatology International 33:4, pages 1079-1082.
Crossref
Crossref
Matthew W. Davis, Suman Wason & Jennifer L. DiGiacinto. (2013) Colchicine-Antimicrobial Drug Interactions: What Pharmacists Need to Know in Treating Gout. The Consultant Pharmacist 28:3, pages 176-183.
Crossref
Crossref
Suman WasonJennifer L. DiGiacintoMatthew W. Davis. (2013) Clinically Significant Pharmacokinetic Interaction between Colchicine and Ritonavir in Healthy Volunteers. Clinical Medicine Insights: Therapeutics 5, pages CMT.S10561.
Crossref
Crossref
Robert A Terkeltaub, H Ralph Schumacher, John D Carter, Herbert SB Baraf, Robert R Evans, Jian Wang, Shirletta King-Davis & Steven P Weinstein. (2013) Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Research & Therapy 15:1, pages R25.
Crossref
Crossref
Michael T. Murray. 2013. Textbook of Natural Medicine. Textbook of Natural Medicine
1400
1405
.
Fernando Perez-Ruiz & Ana Maria Herrero-Beites. (2012) Evaluation and Treatment of Gout as a Chronic Disease. Advances in Therapy 29:11, pages 935-946.
Crossref
Crossref
Rodolfo V. Curiel & Nicolas J. Guzman. (2012) Challenges Associated with the Management of Gouty Arthritis in Patients with Chronic Kidney Disease: A Systematic Review. Seminars in Arthritis and Rheumatism 42:2, pages 166-178.
Crossref
Crossref
Dinesh Khanna, Puja P. Khanna, John D. Fitzgerald, Manjit K. Singh, Sangmee Bae, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez‐Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger & Robert Terkeltaub. (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care & Research 64:10, pages 1447-1461.
Crossref
Crossref
Dinesh Khanna, John D. Fitzgerald, Puja P. Khanna, Sangmee Bae, Manjit K. Singh, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez‐Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger & Robert Terkeltaub. (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care & Research 64:10, pages 1431-1446.
Crossref
Crossref
Francesco Bolzetta, Nicola Veronese, Marco Mosele, Giuseppe Sergi, Enzo Manzato & Valter Giantin. (2012) A case of naturally evolving gout in an elderly man. Archives of Gerontology and Geriatrics 55:2, pages 497-498.
Crossref
Crossref
Jennifer A Shannon & Sabrina W Cole. (2012) Pegloticase: A Novel Agent for Treatment-Refractory Gout. Annals of Pharmacotherapy 46:3, pages 368-376.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Rheumatology 24:2, pages 237-244.
Crossref
Crossref
Peter M. ten Klooster, Harald E. Vonkeman & Mart A.F.J. van de Laar. (2012) Disability due to gouty arthritis. Current Opinion in Rheumatology 24:2, pages 139-144.
Crossref
Crossref
Evangelos Falidas, Efstathios Rallis, Vasiliki-Kalliopi Bournia, Stavros Mathioulakis, Emmanouil Pavlakis & Constantinos Villias. (2011) Multiarticular chronic tophaceous gout with severe and multiple ulcerations: a case report. Journal of Medical Case Reports 5:1.
Crossref
Crossref
Keith Rome, Mike Frecklington, Peter Mcnair, Peter Gow & Nicola Dalbeth. (2011) Footwear characteristics and factors influencing footwear choice in patients with gout. Arthritis Care & Research 63:11, pages 1599-1604.
Crossref
Crossref